Serum amyloid A and risks of all-cause and cardiovascular mortality in chronic kidney disease: a systematic review and dose-response meta-analysis

Serum amyloid A and risks of all-cause and cardiovascular mortality in chronic kidney disease: a systematic review and dose-response meta-analysis

AbstractBackgrounds The available literature on the correlation between serum amyloid A (SAA) and prognosis of chronic kidney disease (CKD) are limited, and the findings from existing studies are inconclusive. This meta-analysis aimed to evaluate the available evidence regarding the link between SAA...

Full description

Bibliographic Details
Main Authors: Li Li, Hongli Liu, Qinglin Zhang, Hao Jin, Hui Tao, Rong Zhu, Zhongwei Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
Serum amyloid A
chronic kidney disease
all-cause mortality
cardiovascular mortality
dose-response relationship
meta-analysis
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2023.2250877

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2023.2250877

Similar Items